At AtaCor Medical, we envision a new world of cardiac rhythm management. As a result, we are designing innovative solutions to deliver temporary, interim, and permanent cardiac pacing when, and where it matters most. Representing the future of temporary pacing without the risks, costs, and drawbacks of traditional methods, the AtaCor EV Temporary Pacing Lead System is designed to:
- Enable reliable, prompt, imaging-free temporary pacing with safe post-procedure ambulation
- Eliminate the complications associated with transvenous leads
- Eliminate the patient discomfort of transcutaneous pacing
The AtaCor EV Temporary Pacing System is under development and not approved for sale in any geography.
- Enable reliable, prompt, imaging-free temporary pacing with safe post-procedure ambulation
- Eliminate the complications associated with transvenous leads
- Eliminate the patient discomfort of transcutaneous pacing
The AtaCor EV Temporary Pacing System is under development and not approved for sale in any geography.
Location: United States, California, San Clemente
Employees: 11-50
Phone: +1 949-482-1038
Total raised: $61.8M
Founded date: 2014
Investors 3
| Date | Name | Website |
| - | aMoon Fund | amoon.fund... |
| - | BayMed Ven... | baymedvp.c... |
| - | Catalyst H... | chv.vc |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 25.04.2024 | Series C | $28M | - |
| 02.05.2020 | Series B | $25M | - |
| 18.09.2018 | Series A | $8.8M | - |
Mentions in press and media 7
| Date | Title | Description |
| 25.04.2024 | AtaCor Medical Closes $28M Series C Financing | AtaCor Medical, a San Clemente, CA-based medical device company, raised $28M in Series C funding. The round was led by Arboretum Ventures and included existing investors Longview Ventures, Hatteras Venture Partners, Catalyst Health Ventures... |
| 02.05.2020 | Cardiac Pacing Company AtaCor Raises $25 Million | AtaCor Medical announced it has raised $25 million in Series B funding led by a corporate partner AtaCor Medical announced it has raised $25 million in Series B funding led by a corporate partner and includes existing investors Broadview Ve... |
| 29.04.2020 | AtaCor Medical Raises $25M in Series B Funding | AtaCor Medical, a San Clemente, CA-based medical device company, completed a $25M Series B financing. The round was led by a corporate partner, with participation from Broadview Ventures and aMoon Fund as well as new investors Hatteras Vent... |
| 28.04.2020 | AtaCor Medical Secures $25M Series B | SAN CLEMENTE, Calif.--(BUSINESS WIRE)--AtaCor Medical, Inc. announced today that is has completed a $25M Series B financing. The financing syndicate, led by a corporate partner, includes existing investors Broadview Ventures and aMoon Fund ... |
| 28.04.2020 | AtaCor Medical Secures $25M Financing to Continue Extracardiac Pacing Development | SAN CLEMENTE, Calif.–(BUSINESS WIRE)–April 28, 2020– AtaCor Medical, Inc. announced today that is has completed a $25M Series B financing. The financing syndicate, led by a corporate partner, includes existing investors Broadview Ventures a... |
| - | AtaCor Medical | “PROTECTTHE HEART STAYEXTRAVASCULAR Transforming cardiac rhythm management with novel extravascular leads and deployment systems designed to eliminate the risks, costs, and drawbacks of traditional transvenous leads Pacing Defibrillation PR... |
| - | AtaCor Medical | “AtaCor Medical - Designing innovative solutions to deliver temporary, interim, and permanent cardiac pacing when, and where it matters most.” |